Abstract:Patients with primary cutaneous melanocytic lesions rely not only on the knowledge, skills, and experience of their treating clinician but also on the fundamentally important input of their pathologist for accurate diagnosis and appropriate management. Free and precise communication between pathologists and surgeons is important and undoubtedly improves patient care, particularly when managing difficult or complicated cases. To provide both patient and surgeon with the necessary information they require to make the most appropriate decisions, the pathology report should include all pathologic factors that are important in determining the patient's prognosis and management. Use of a synoptic format for pathology reporting of melanomas can facilitate this. Recent studies have established that the dermal mitotic rate of a primary cutaneous melanoma is a major prognostic determinant, and have shown that its assessment and that of other important histopathologic prognostic variables are reproducible between pathologists. Sentinel node (SN) biopsy has provided a minimally invasive procedure that can accurately predict the regional node status of melanoma patients. It is well demonstrated that the use of immunohistochemical stains assists in the detection of melanoma micrometastases in SNs, although it remains unclear which is the optimal pathologic protocol for SN evaluation and whether there is a role for reverse transcriptase polymerase chain reaction (RT-PCR) in SN assessment. False negative SN biopsies may occur as a result of errors in lymphatic mapping or sentinel lymphadenectomy, or because of a deficiency in the process of histopathologic evaluation. Recent studies have shown that the likelihood of non-SN involvement when the SN is positive correlates mostly with the extent of SN involvement, in particular the tumor penetrative depth (defined as the maximum distance of melanoma cells from the inner margin of the SN capsule). It appears that assessment of the micromorphometric features of positive SNs may be useful in predicting which patients have a low probability of having metastatic tumor in non-SNs, and therefore in selecting patients who potentially may be spared a completion lymph node dissection. It is likely that future advances in our understanding of the molecular biology of melanoma will provide new insights into tumor classification, improve diagnostic accuracy and prognostic ability, and lead to the development of more precisely targeted therapies.

Non-neoplastic bone, joint, and soft tissue pathology: What every pathologist should know

Updates in non-neoplastic orthopaedic pathology: what you don't know can hurt you!

Molecular pathology of soft tissue and bone tumors. A review

Essentials of pathologic diagnosis in soft tissue tumor

Basic Principles and Specialized Techniques

Recent advances in molecular profiling of bone and soft tissue tumors

Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update

Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors

Pathology of intra-articular tumours and tumour-like lesions: pearls, pitfalls and rarities from a general surgical pathology practice

Benign Bone Tumors: An Overview of What We Know Today

Back to the future! Selected bone and soft tissue neoplasms with shared genetic alterations but differing morphological and immunohistochemical phenotypes

[Pathology of soft tissue sarcomas]

Bone and Soft-Tissue Biopsies: What You Need to Know

Neoplastic and Non-neoplastic Bone Lesions of the Knee

Computational Pathology: Challenges and Promises for Tissue Analysis

Bone Biopsies: Practical Considerations and Technical Tips

Pathology of melanocytic lesions: New, controversial, and clinically important issues

Role of Histopathology in diagnosis of Soft Tissue Tumors at Tertiary Care Center

Computational pathology in cancer diagnosis, prognosis, and prediction – present day and prospects

Computational Pathology: A Survey Review and The Way Forward

Not every knee tumour is a ganglion - retrospective analysis of benign and malign tumour entities around the knee